Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Estrogen affects hair growth and skin cell multiplication.

The formulation with oleic acid may be better for treating male pattern baldness.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

The effects of estrogen on human hair growth are unclear and need more research.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

The cream effectively and safely reduces facial hair in women.

The lotion with equol, dihomo-γ-linolenic acid, and propionyl-l-carnitine was effective in reducing hair loss in men and women.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Spironolactone can reduce hair growth in women with hirsutism.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.